Burosumab-twza Subcutaneous and Hyperphosphatemia
Result of checking the interaction of drug Burosumab-twza Subcutaneous and disease Hyperphosphatemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Do not initiate burosumab-twza treatment if serum phosphorus is within or above the normal range for age. Increases in serum phosphorus to above the upper limit of normal may be associated with an increased risk of nephrocalcinosis. It is recommended to obtain baseline fasting serum phosphorus levels and to monitor fasting serum phosphorus levels. Dose interruption and/or dose reduction may be required based on a patient's serum phosphorus levels.
Generic Name: burosumab
Brand Name: Crysvita
Synonyms: Burosumab